BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4322637)

  • 1. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase.
    Smith JB; Mills DC
    Biochem J; 1970 Dec; 120(4):20P. PubMed ID: 4322637
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors.
    Asano T; Ochiai Y; Hidaka H
    Mol Pharmacol; 1977 May; 13(3):400-6. PubMed ID: 195193
    [No Abstract]   [Full Text] [Related]  

  • 3. Human brain and platelet cyclic adenosine 3',5'-monophosphate phosphodiesterases: different response to drugs.
    Pichard AL; Hanoune J; Kaplan JC
    Biochim Biophys Acta; 1972 Aug; 279(1):217-20. PubMed ID: 4347078
    [No Abstract]   [Full Text] [Related]  

  • 4. Is adenosine involved in inhibition of forskolin-stimulated cyclic AMP accumulation by caffeine in rat brain?
    Mante S; Minneman KP
    Mol Pharmacol; 1990 Nov; 38(5):652-9. PubMed ID: 2172772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic 3',5'-adenosine monophosphate in human blood platelets. 3. The role of cyclic AMP in platelet aggregation.
    Salzman EW; Rubino EB; Sims RV
    Ser Haematol; 1970; 3(4):100-13. PubMed ID: 4329913
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.
    Mills DC; Smith JB
    Biochem J; 1971 Jan; 121(2):185-96. PubMed ID: 4330088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of drugs on the activity of thrombocytes 3,5-cyclic AMP phosphodiesterase.
    Rysánek K; Spánkova H; Mlejnkova M; Synek P
    Int J Clin Pharmacol; 1974 Jul; 10(1):30-2. PubMed ID: 4368616
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of platelet cyclic 3',5'-adenosine-monophosphate phosphodiesterases by pentifylline.
    Stefanovich V
    Arzneimittelforschung; 1975 May; 25(5):740-1. PubMed ID: 170944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of pentoxifyllin on the cyclic AMP-system in thrombocytes].
    Stefanovich V; Jarvis P; Grigoleit HG
    Med Welt; 1975 Dec; 26(49):2230-3. PubMed ID: 1626
    [No Abstract]   [Full Text] [Related]  

  • 11. [A sensitive method to determine cyclic adenosine monophosphate in platelets (author's transl)].
    Zhang XY; Ren SQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1980 Jun; 8(2):142-4. PubMed ID: 6273093
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of electrical pulses and elevated levels of potassium ions as stimulants of adenosine 3', 5'-monophosphate (cyclic AMP) accumulation in guinea-pig brain.
    Zanella J; Rall TW
    J Pharmacol Exp Ther; 1973 Aug; 186(2):241-52. PubMed ID: 4146353
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of high affinity ATP-dependent cyclic nucleotide transporters by specific and non-specific cyclic nucleotide phosphodiesterase inhibitors.
    Aronsen L; Orvoll E; Lysaa R; Ravna AW; Sager G
    Eur J Pharmacol; 2014 Dec; 745():249-53. PubMed ID: 25445042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyclic AMP phosphodiesterase inhibitors on cardiac sarcolemmal 5'-nucleotidase.
    Heyliger CE; Panagia V; Dhalla NS
    J Pharmacol Exp Ther; 1981 May; 217(2):489-93. PubMed ID: 6262487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new cGMP phosphodiesterase isolated from bovine platelets is substrate for cAMP- and cGMP-dependent protein kinases: evidence for a key role in the process of platelet activation.
    Robichon A
    J Cell Biochem; 1991 Oct; 47(2):147-57. PubMed ID: 1661738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of syntophyllin and caffeine on the level and uptake of serotonin by thrombocytes and their effect on the inhibition of thrombocyte aggregation.
    Rysánek K; König J; Růzicková S; Spánková H
    Act Nerv Super (Praha); 1972; 14(2):135-6. PubMed ID: 4339151
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of cyclic AMP on transformation and proliferation of leishmania cells.
    Walter RD; Buse E; Ebert F
    Tropenmed Parasitol; 1978 Dec; 29(4):439-42. PubMed ID: 217133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
    Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
    J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of renal ecto-phosphodiesterase.
    Jackson EK; Ren J; Zacharia LC; Mi Z
    J Pharmacol Exp Ther; 2007 May; 321(2):810-5. PubMed ID: 17308037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.